Effects of systemic or topical administration of sodium selenite on early radiation effects in mouse oral mucosa

Strahlentherapie und Onkologie

Volumn 183, Issue 1, 2007, Pages 36-42

  Gehrisch, Anja ^a   Dörr, Wolfgang ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

Fractionated irradiation; Mouse model; Mucoprotection; Oral mucositis; Selenium

Indexed keywords

SELENASE; SELENITE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DOSE RESPONSE; EPITHELIUM; FRACTIONATION; IRRADIATION; MOUSE; MOUTH ULCER; MUCOSA INFLAMMATION; NONHUMAN; QUANTITATIVE ANALYSIS; RADIATION DOSE; RADIATION INJURY; TONGUE;

ADMINISTRATION, TOPICAL; ANIMALS; INJECTIONS, INTRA-ARTERIAL; MICE; MICE, INBRED C3H; MOUTH MUCOSA; RADIATION INJURIES; RADIATION-PROTECTIVE AGENTS; SODIUM SELENITE; STOMATITIS;

EID: 33846446030     PISSN: 01797158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00066-007-1594-4     Document Type: Article

References (19)

1. Breccia A, Badiello R, Trenta A, et al. On the chemical radioprotection by organic selenium compounds in vivo. Radiat Res 1969;38:483-92.
2. Bruns F, Büntzel J, Mücke R, et al. Selenium in the treatment of head and neck lymphedema. Med Princ Pract 2004;13:185-90.
3. Bruns F, Micke O, Bremer M. Current status of selenium and other treatments for secondary lymphedema. J Support Oncol 2003;1:121-30.
4. Dörr W. Modulation of repopulation processes in oral mucosa: experimental results. Int J Radiat Biol 2003;79:531-7.
5. Dörr W. Effects of selenium on radiation responses of tumor cells and tissue. Strahlenther Onkol 2006;182:693-5
6. Dörr W, Brankovic K, Hartmann B. Repopulation in mouse oral mucosa: changes in the effect of dose fractionation. Int J Radiat Biol 2000;76:383-90.
7. Dörr W, Hendry JH. Consequential late effects in normal tissues. Radiother Oncol 2001;61:223-31.
8. Dörr W, Kummermehr J. Accelerated repopulation of mouse tongue epithelium during fractionated irradiations or following single doses. Radiother Oncol 1990;17:249-59.
9. Dörr W, Reichel S, Spekl K. Effects of keratinocyte growth factor (palifermin) administration protocols on oral mucositis (mouse) induced by fractionated irradiation. Radiother Oncol 2005;75:99-105.
10. Epstein JB, Schubert MM. Oropharyngeal mucositis in cancer therapy. Review of pathogenesis, diagnosis, and management. Oncology (Huntingt) 2003;17:1767-92.
11. Herrmann T, Baumann M. Prolongation of latency or overall treatment time by unplanned radiation pauses. The clinical importance of compensation. Strahlenther Onkol 2005;181:65-76.
12. Jereczek-Fossa BA, Morra A, DeBraud F, et al. Hyperfractionated radiotherapy in locally advanced nasopharyngeal cancer. An analysis of 43 consecutive patients. Strahlenther Onkol 2004;180:425-33.
13. Kovacs AF, Mose S, Bottcher HD, et al. Multimodality treatment including postoperative radiation and concurrent chemotherapy with weekly docetaxel is feasible and effective in patients with oral and oropharyngeal cancer. Strahlenther Onkol 2005;181:26-34.
14. Saadeh CE. Chemotherapy- and radiotherapy-induced oral mucositis: review of preventive strategies and treatment. Pharmacotherapy 2005;25:540-4.
15. Sagowski C, Wenzel S, Jenicke L, et al. Sodium selenite is a potent radioprotector of the salivary glands of the rat: acute effects on the morphology and parenchymal function during fractionated irradiation. Eur Arch Otorhinolaryngol 2005;262:459-64.
16. SAS Institute. SAS/STAT user's guide version 6. Cary: SAS Institute, 1990.
17. Scully C, Epstein J, Sonis S. Oral mucositis: a challenging complication of radiotherapy, chemotherapy, and radiochemotherapy: part 1, pathogenesis and prophylaxis of mucositis. Head Neck 2003;25:1057-70.
18. Weiss JF, Landauer MR. Radioprotection by antioxidants. Ann N Y Acad Sci 2000;899:44-60.
19. Weiss JF, Srinivasan V, Kumar KS, et al. Radioprotection by metals: selenium. Adv Space Res 1992;12:223-31.